A method for identifying a patient likely to have, or at risk of developing, Type II diabetes or insulin resistance is provided. The method is performed by identifying an expression profile typical of Type II diabetes in which selected genes are upregulated and/or selected genes are downregulated. This expression profile correlates with an A3243G mutation level of 10% to 55%.
申请公布号
WO2005058142(A3)
申请公布日期
2006.03.02
申请号
WO2004US42110
申请日期
2004.12.16
申请人
EMORY UNIVERSITY;WALLACE, DOUGLAS, C.;LEVY, SHAWN;KERSTANN, KEITH;PROCACCIO, VINCENT
发明人
WALLACE, DOUGLAS, C.;LEVY, SHAWN;KERSTANN, KEITH;PROCACCIO, VINCENT
